DK0610357T3 - Transdermal therapeutic systems with crystallization inhibitors - Google Patents

Transdermal therapeutic systems with crystallization inhibitors

Info

Publication number
DK0610357T3
DK0610357T3 DK92922822.9T DK92922822T DK0610357T3 DK 0610357 T3 DK0610357 T3 DK 0610357T3 DK 92922822 T DK92922822 T DK 92922822T DK 0610357 T3 DK0610357 T3 DK 0610357T3
Authority
DK
Denmark
Prior art keywords
transdermal therapeutic
therapeutic systems
crystallization inhibitors
crystallization
inhibitors
Prior art date
Application number
DK92922822.9T
Other languages
Danish (da)
Inventor
Ralph Lipp
Jutta Riedl
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0610357T3 publication Critical patent/DK0610357T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Described is a transdermal therapeutic system which is characterized in that it includes a crystallization inhibitor, and optionally also penetration enhancers, in an adhesive matrix containing the active substance.
DK92922822.9T 1991-10-31 1992-10-21 Transdermal therapeutic systems with crystallization inhibitors DK0610357T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4210711A DE4210711A1 (en) 1991-10-31 1992-03-27 TRANSDERMAL THERAPEUTIC SYSTEMS WITH CRYSTALIZATION INHIBITORS

Publications (1)

Publication Number Publication Date
DK0610357T3 true DK0610357T3 (en) 1998-05-11

Family

ID=25908725

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92922822.9T DK0610357T3 (en) 1991-10-31 1992-10-21 Transdermal therapeutic systems with crystallization inhibitors

Country Status (14)

Country Link
EP (1) EP0610357B1 (en)
JP (1) JP3526864B2 (en)
AT (1) ATE158181T1 (en)
AU (2) AU2895392A (en)
CA (1) CA2120599C (en)
DE (2) DE4210711A1 (en)
DK (1) DK0610357T3 (en)
ES (1) ES2106888T3 (en)
FI (1) FI110061B (en)
GR (1) GR3025237T3 (en)
HU (1) HU227531B1 (en)
NO (1) NO307644B1 (en)
PT (1) PT101019B (en)
WO (1) WO1993008795A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH08512054A (en) * 1993-06-25 1996-12-17 アルザ・コーポレーション Inclusion of poly-N-vinylamide in transdermal system
DE4333595A1 (en) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermal therapeutic system for applying drugs to the skin
DE4405899A1 (en) * 1994-02-18 1995-08-24 Schering Ag Agent for transdermal application containing desogestrel
DE4429667C2 (en) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol TTS with water-binding additives and process for its preparation
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Compositions for transdermal delivery of acid-labile drugs
DE19500662C2 (en) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Plaster containing estradiol and its use
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
IL122432A (en) † 1995-06-07 2000-07-16 Cygnus Therapeutic Systems Transdermal patch for preventing ovulation
DE19526864A1 (en) * 1995-07-22 1997-01-23 Labtec Gmbh Hormone patches
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (en) * 1996-07-11 1998-01-15 Schering Ag Transdermal therapeutic systems
DE19649535C2 (en) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Process for the production of a plaster-shaped therapeutic system
DE19701949A1 (en) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermal therapeutic system
GB9720470D0 (en) * 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (en) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms
DE19829713C1 (en) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutic system with the addition of pearlescent pigments
DE19834006A1 (en) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiol-containing patch for the transdermal application of hormones
DE19843027A1 (en) * 1998-09-19 2000-03-23 Labtec Gmbh Transdermal therapeutic system used for administration of sex hormones contains neohesperidin dihydrochalcone to inhibit crystallization of active agent
DE10012908B4 (en) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilized supersaturated transdermal therapeutic matrix systems and methods for their preparation
DE10033853A1 (en) * 2000-07-12 2002-01-31 Hexal Ag Transdermal therapeutic system, containing highly dispersed silicon dioxide in matrix or adhesive layer to promote drug permeation through the skin
CN100391462C (en) * 2001-06-18 2008-06-04 诺芬药品公司 Enhanced drug delivery in transdermal systems
BRPI0414551B8 (en) 2003-10-10 2021-05-25 Antares Pharma Ipl Ag transdermal or transmucosal pharmaceutical formulation and method of delaying or inhibiting crystallization of an active agent
WO2006093139A1 (en) 2005-02-28 2006-09-08 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP5546013B2 (en) 2008-02-27 2014-07-09 久光製薬株式会社 Patches and packaging
ES2536206T3 (en) 2008-02-27 2015-05-21 Hisamitsu Pharmaceutical Co., Inc. Medicinal patch
EP2258396B1 (en) 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
DE102010040299A1 (en) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
ES2841138T3 (en) * 2013-09-11 2021-07-07 Medrx Co Ltd Novel base composition for adhesive tape agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (en) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts OSTROGEN-ACTIVE PLASTER
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (en) * 1990-04-06 1995-12-13 積水化学工業株式会社 Nitroglycerin patch

Also Published As

Publication number Publication date
ES2106888T3 (en) 1997-11-16
WO1993008795A1 (en) 1993-05-13
EP0610357A1 (en) 1994-08-17
FI942011A (en) 1994-04-29
JPH07506083A (en) 1995-07-06
CA2120599C (en) 2003-04-15
FI110061B (en) 2002-11-29
HU227531B1 (en) 2011-07-28
AU712692B2 (en) 1999-11-11
NO941593L (en) 1994-04-29
DE4210711A1 (en) 1993-05-06
AU2895392A (en) 1993-06-07
ATE158181T1 (en) 1997-10-15
PT101019B (en) 1999-10-29
EP0610357B1 (en) 1997-09-17
PT101019A (en) 1994-02-28
DE59208918D1 (en) 1997-10-23
HUT72964A (en) 1996-06-28
GR3025237T3 (en) 1998-02-27
FI942011A0 (en) 1994-04-29
NO941593D0 (en) 1994-04-29
NO307644B1 (en) 2000-05-08
CA2120599A1 (en) 1993-05-13
JP3526864B2 (en) 2004-05-17
AU1652997A (en) 1997-05-29
HU9401257D0 (en) 1994-08-29

Similar Documents

Publication Publication Date Title
DK0610357T3 (en) Transdermal therapeutic systems with crystallization inhibitors
FI940427A0 (en) Transdermal therapeutic systems
DE69426988T2 (en) TRANSDERMAL DELIVERY DEVICE
DK0744944T3 (en) Transdermal therapeutic systems containing genital periods
MY109727A (en) Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
ITTO960469A0 (en) DEVICE FOR THE TRANSDERMAL ADMINISTRATION BY ELECTROTRANSPORT OF FENTANIL AND SUFENTANIL.
ATE209940T1 (en) IMPROVED TRANSDERMAL DEVICE WITH REDUCED DELAMINATION
ES2147858T3 (en) MATRIX FOR THE TRANSDERMIC SUPPLY OF PHARMACES.
MX9203755A (en) IONTOPHORETICAL SUPPLY DEVICE FOR DRUGS OR THERAPEUTIC AGENTS, EQUIPPED WITH AN ADHESIVE OF ELECTRO-TRANSPORTATION.
ATE162945T1 (en) AGENTS FOR TRANSDERMAL APPLICATION CONTAINING 3-KETO-DESOGESTREL
NO974508D0 (en) Transdermally administrable drug with ACE inhibitors
ATE293960T1 (en) TRANSDERMAL DEVICE FOR ADMINISTRATION OF TESTOSTERONE
DE59308256D1 (en) DEXPANTHENOL-CONTAINING PLASTER FOR TRANSDERMAL APPLICATION OF STEROID HORMONES
DK0650359T3 (en) Transdermal therapeutic system with the active substance 17-beta-estradiol (anhydrous)
DK0794770T3 (en) Transdermal preparation containing a loratidine metabolite with antihistamine action
DE59712215D1 (en) TRANSDERMALES THERAPEUTIC SYSTEM WITH A BISPHOSPHATE COMBINATION CONTAINING OSTRIOLS